関連する実験動画
Updated: Feb 21, 2026

08:35
Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
8.4K
BCL-2はどんな作用をするのか? 新しい分子洞察から臨床的影響まで
Carlo M Croce1, Stephen W G Tait2,3, Ana J Garcia-Sáez4,5
1Department of Cancer Biology and Genetics and Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. Carlo.Croce@osumc.edu.
Cell death and differentiation
|February 19, 2026
まとめ
数十年にわたるBCL-2ファミリータンパク質の研究は,BCL-2阻害剤の開発につながり,アポトーシスを標的としてがん治療に革命をもたらしました. 耐性メカニズムを理解し,新しい治療法を探求することは,がん治療の将来の進歩の鍵です.
科学分野:
- がん生物学 がん生物学
- 分子生物学は分子生物学である.
- 免疫学 免疫学とは
背景:
- BCL-2タンパク質ファミリーは,細胞死における重要なプロセスであるアポトーシスを調節します.
- BCL-2の調節不良は,特にリンパ性悪性腫瘍において,がんの病原化に寄与する.
- ミトコンドリア外膜浸透 (MOMP) は,BCL-2によって調節されるアポトーシスの重要なイベントです.
研究 の 目的:
- BCL-2の発見から臨床阻害剤の開発までの経緯を振り返る.
- アポトーシス調節におけるBCL-2のメカニズムと癌におけるその役割について議論する.
- BCL-2標的療法における課題,耐性メカニズム,および将来の方向性を探求する.
主な方法:
- BCL-2の研究に関する文献レビュー,基礎科学から臨床応用まで.
- BCL-2ファミリーの相互作用とそのアポトーシスにおける役割の分析.
- 血液学的悪性腫瘍におけるヴェネトクラックスなどのBCL-2阻害剤の臨床データの検討.
主要な成果:
- ベネトクラックスなどのBCL-2阻害剤は,慢性リンパ球性白血病 (CLL) と急性骨髄性白血病 (AML) の治療において有意な成功を収めている.
- BCL-2阻害剤に対する抵抗は,BCL-2変異またはMCL-1のような他の抗アポプトシスタンパク質のアップレギュレーションから生じる可能性があります.
- 亜致死性MOMPは炎症反応を誘発し,代替治療標的を提供することができます.
結論:
- BCL-2を標的とした治療は,がん治療,特に血液学的がんの治療に変革をもたらしました.
- 耐性を克服し,BCL-2阻害剤の有効性を固体腫瘍に拡大することは,依然として重要な課題です.
- 将来の研究は,新しい阻害剤,組み合わせ療法,BCL-2の非アポプトティックな役割を理解することに焦点を当てるべきです.
関連する概念動画
The Intrinsic Apoptotic Pathway
8.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K
PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
NF-κB-dependent Signaling Pathway
10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.1K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K

